Although YWHAZ has also been reported to act as a tumor suppressor during bladder cancer development 32, 33, our results consistently show that YWHAZ overexpression negatively regulates apoptosis, enabling cellular adaptation to the presence of chemotherapeutic drugs. The gene discussed is YWHAZ; the disease is urinary bladder carcinoma.